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STUDENT ARTICLES

PROHIBITING AIDS TESTING IN THE HEALTH
INSURANCE CONTEXT: PATCHING UP A
PATCHWORK SYSTEM
SUZANNE

M.

RUSSELL*

AIDS has shown in harsh light the cracks and flaws and
holes in the American health care system. It is a crystallization of the worst problems in preventing illness and
caring for the sick. AIDS has shown that our insurance
system is unfair. If you lose your job - because of economics or because of illness - you lose your insurance.
AIDS has shown that Medicaid is shallow and inadequate.
AIDS has shown that we can produce medical miracles
for the rich and plain neglect for the poor. AZT is priced
for kings and Medicaid is for people who have been made
paupers. These failures, however, are not unique to
AIDS. AIDS has only shown them in bold relief.'
Since the onset of Acquired Immune Deficiency Syndrome
(AIDS) in 1981, Americans have been terrified by the disease's
severity and finality. We have been deluged with information
concerning such topics as how one can and cannot contract
AIDS in schools or in the workplace or in the home. As the
number of AIDS victims has grown, the issue of the cost of caring for AIDS patients, many of whom are uninsured, has
sparked particularly intense debate. Who should pay for the
treatment of those AIDS patients who have neither financial
resources nor insurance? The AIDS crisis has highlighted the
inherent weakness of our "patchwork" health care system, a
system that is comprised of various public and private segments
*
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1. Statement of Rep. Henry Waxman (D. Calif.), Chairman of the
House Energy and Commerce Subcommittee on Health and the
Environment, reprinted in Dunne, Who Should Bear the Costs of AIDS Care?, USA
TODAY, May 1988, at 30, 31.
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and that, to a large extent, relies on private means to pay for
health care - a general social welfare need.2 As a result, the
system excludes those who lack the requisite resources, and
consequently, their basic health care needs are not met. Our
system of health insurance, in which private companies strive to
limit their own risk and to ensure their own profitability, can
protect the healthy while systematically rejecting the sick either
by refusing to cover them or by charging them unaffordable
premiums. 3
Unfortunately, the insurance industry has won the privilege of being able to require all applicants for individual health
insurance policies to be tested for AIDS. A 1988 Congressional survey revealed that most insurers exercised this right.
Moreover, companies routinely deny coverage to those who are
infected. 4 Health insurers should not be allowed to screen prospective insureds for human immunodeficiency virus (HIV)
infection, and policymakers should not let them. The primary
goal of public policy should be to achieve justice in society. A
just society, consisting of both public and private spheres,
should provide for the basic needs of its citizens - those needs
which relate to well-being. Health care is such a basic need.
Unlike many other countries, the United States, in its peculiarly
"patchwork" system relies on the cooperative efforts of public
and private hospitals and insurers to provide health care. But,
AIDS has stunned the system, and private insurers have sometimes tried to insulate themselves from this disease's high costs
by screening the blood of prospective insureds. However, this
practice contradicts the social obligation of health insurers.
Specifically, it exempts insurers who, because they have
achieved and maintained a preeminent role in our health care
system, have a concomitant duty along with other players in the
health care sector to fulfill their role responsibly. Certainly,
neither insurance companies, the public sector, for-profit and
not-for-profit hospitals, nor any private individual should be
unduly strained. Accordingly, the most equitable way to spare
any single element of society from excessive burden is to reach
a compromise which "spreads the risk" among these entities.
2. Oppenheimer & Padgug, AIDS: The Risks to Insurers, the Threat to
Equity, HASTINGS CENTER REP., May 1986, at 18.
3. Id. at 19. See also Lambert, Insurance Limits Growing to Curb AIDS

Coverage, N.Y. Times, Aug. 7, 1989, at Al, col. 1 (reporting that one company
rejected all applicants from San Francisco and that coverage has been denied
to unmarried men, or to men with jobs like hairdressing, that are
stereotypically associated with gay and bisexual men).
4. Lambert, supra note 3.

AIDS AND INSURANCE

1990]

In this way, our scarce health care resources will be directed to
those who most need them, and the resources of neither the
public nor the private spheres of society will be unfairly
depleted.
This student article will summarize the basic principles of
health insurance. In addition, it will discuss why social concerns, distributive justice, and Catholic Church teaching mandate that health insurers be prohibited from testing the blood
of prospective insureds. Finally, it will explore how AIDS is
currently being treated, how costs for these treatments are currently being allocated and could possibly be reduced, and how
private insurers could and should participate in assuming some
of the costs. The following proposals for improving access to
health care for AIDS patients will be developed:
1) Health insurers should not be allowed to test prospective insureds for the human immunodeficiency virus
(HIV), or to deny coverage based on AIDS-related
information.
2) Companies who make drugs that are effective in combatting AIDS should not take advantage of the vulnerable positions of the afflicted by charging excessive
prices. They should cooperate with patients, and private and public insurers to provide their products at a
reasonable cost and accrue a reasonable profit. Moreover, promising experimental drugs should be more
accessible. Private insurers can help to accomplish
this goal by expanding their coverage to include these
drugs.
3) Nontraditional methods of care, (home health care,
hospices, visiting nurse programs), which are generally less expensive than inpatient hospital care, should
be encouraged. Insurers should cover such care and
hospitals should seek to foster programs in their own
communities.
I.

INSURANCE LAw THEORY

Insurance is contractual in nature, and insurance underwriting is based upon the distribution of risk among the
insured. This process is regulated by insurance law and
presents enormous economic and social implications. Insurance is a free-market enterprise seeking to be profitable like
other for-profit organizations. Yet it has a responsibility to the
community. Like any other component of the legal system, the
goal of insurance law should be to ensure justice. Accordingly,
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health insurance law should strike a balance between economic
efficiency and access to care in a just manner to help ensure
that the needs of AIDS patients are met.
A.

Insurance Mechanics

By definition, insurance is a contract in which, in exchange
for money, one party assumes the risks of another and
promises to pay a sum of money in the event of a certain contingency.5 Actuarial and underwriting principles are integral to
the health insurance industry.6 Actuaries are responsible for
rate making - the establishment of premium rates for insurance products. Actuaries must set premiums appropriately to
ensure that the insurance company can meet claims and operating expenses. 7 The actuarial functions of health insurance
focus upon morbidity statistics, that is, the probability that a
person at a certain age will incur illness or disability.8 Insurance company underwriting departments assess applications
for insurance and classify them for risk. Health insurers consider both medical and nonmedical factors in evaluating applications for coverage. After they accumulate and analyze
relevant information, underwriters assign individuals to risk
classes - groups of people whose risk to the insurance company is similar.9 They consider additional factors in underwriting individual health insurance policies. First, insurers must
contend with the problem of "antiselection." Antiselection
refers to one's purchase of health insurance in order to acquire
benefits for a condition of which the insurance company is not
aware. Pre-existing condition provisions in policies protect
insurance companies from antiselection, typically by stating
that one may not collect benefits for a specified period (usually
two years) for a condition that was apparent before the date of
issue and was not disclosed on the application.' ° Second,
insurers may modify insurance to reduce their risk. For example, the insurer may reduce the benefit paying period of the
policy or reduce the benefit amount. Additionally, the insurer
5.

44 C.J.S. Insurance § 1 (1945).

6. Since this article addresses individual rather than group insurance,
actuarial functions for individual insurance policies will be examined. For
information on group health insurance, see K. HUGGINS, OPERATIONS OF LIFE
AND HEALTH INSURANCE COMPANIES 176 (1986) and Nussbaum, Group
Insurance and AIDS, BEST'S REV., Apr. 1988, at 26.
7. K. HUGGINS, supra note 6, at 140.
8. Id. at 175.

9. Id. at 194.
10. Id. at 204.
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may increase the waiting period before benefits become payable. Finally, insurers may attach impairment riders limiting or
excluding coverage for specific health impairments."
AIDS presents much uncertainty, particularly in terms of
risk groups and patterns of health care utilization. The unusual, costly, and uncertain nature of AIDS clashes with the conservative nature of insurance underwriting practices.' 2
Accordingly, because of their risk averse tendencies, insurers
have responded in such ways as post-claim underwriting
(attempting to deny benefits to insureds who develop AIDS
after the policy is in effect),'" precluding payments for experimental treatments,' 4 denying benefits based on a theory of preexisting condition,' 5 and rejecting those applicants who
"appear" to be, or who fit a lifestyle prototype of being gay or
bisexual.' 6 In addition to underwriting tools such as medical
histories, and examination of socio-demographic characteristics, private insurers have relied on antibody testing such as the
Enzyme-Linked Immuno-Absorbent Assay (ELISA) or Western
Blot (WB) to screen out poor risks by identifying those infected
with Human Immunodeficiency Virus (HIV). 7
Proponents of testing offer several justifications for such
testing. First, they argue that testing is necessary to keep the
insurance industry intact."8 Second, they maintain that AIDS
should be treated like other diseases.' 9 Finally, they claim that
otherwise, the healthy public will be unreasonably burdened. 0
In contrast, opponents claim that insurers' economic fears are
exaggerated.2 Second, they argue that social costs outweigh
11. Id. at 205. For a criticism of the basically unfettered discretion of
insurance companies in risk classification and an argument for more
government regulation, see Wortham, Insurance Class!/fcation: Too Important to
be Left to the Actuaries, 19 U. MICH. J.L. REFORM 349 (1986).
12. Oppenheimer & Padgug, supra note 2, at 19.
13. Schatz, The AIDS Insurance Crisis: Underuritingor Overreaching?, 100
HARV. L. REV. 1782, 1786 (1987).
14. Id.
15. Id.
16. Id.
17. Oppenheimer & Padgug, supra note 2, at 20.
18. See generally Clifford & luculano, AIDS and Insurance: The Rationalefor
AIDS-Related Testing, 100 HARV. L. REV. 1806 (1987) and Schweiker, Why
Should Insurance Companies Bear All the Costs of AIDS Care?, USA TODAY, May
1988, at 32.
19. Id.
20. Id.
21. Editorial, N.Y. Times, Aug. 8, 1989, at 12, col. 1 and Schatz, supra
note 13, at 1794.

136

NOTRE DAME JOURNAL OF LAW, ETHICS & PUBLIC POLICY

[Vol. 5

the benefits of testing." Third, and most importantly, they say
that testing the blood of AIDS patients can preclude these peo23
ple from access to health care.
II.

WHY HEALTH INSURERS SHOULD BE PROHIBITED FROM
HIV TESTING

Insurance companies should not be allowed to test the
blood of prospective insureds for two general reasons. First,
testing imposes excessive social costs. Second, an adverse
result may, as a practical matter and without changes elsewhere
in the system, preclude one who cannot afford it from access to
needed health care. This outcome contradicts the conditions
of a just society which, as will be shown, should satisfy its citizens' basic needs.
A.

Costs to Society

Four key social costs accompany HIV testing. First, discrimination against gay and bisexual men would probably
result since it is common knowledge they constitute an overwhelmingly high percentage of the AIDS population. In order
to reduce expenses, insurers may want to test only apparently
"high risk" applicants. Accomplishing this would mean identifying those believed to be gay or bisexual, and finding a pretext
24
in an applicant's medical record to justify screening.
Second, HIV testing which ignores the concomitant obligation to provide counseling is counterproductive. In light of
the enormous psychological, economic, medical, and social
implications of a positive HIV result, appropriate counseling
and medical evaluation are essential companions to the screening process.2 5 Such counseling serves two important functions.
First, it educates people who undergo testing about AIDS and
test result interpretation. Second, it helps them to cope with
the emotional problems which they may face in taking the
26
test.

Third, problems with confidentiality are inherent in testing. 2 7 Employers may uncover information about applicants
22.
23.
24.

Schatz, supra note 13, at 1799-1802.
Id. at 1792, 1803.
Id. at 1799. See also Lambert, Insurance Limits Growing to Curb AIDS

Coverage, N.Y. Times, Aug. 7, 1989, at Al, col. 1.
25. Schatz, supra note 13, at 1800 (citing Memorandum of Tom Zuck,
Director of Blood and Blood Products, FDA (Jan. 29, 1986)).
26. Id. at 1800.
27. Id.
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who have been rejected for individually screened small group
coverage. As a result, a person may suffer employment and
sexual orientation discrimination.28
Finally, from a public health standpoint, insurer testing
perpetuates the sense of fear and mistrust associated with AIDS
testing. Accordingly, many public health experts and researchers believe that testing should be restricted to the voluntary or
clinical context. 29 Additionally, questioning applicants about
prior test results serves to discourage them from seeking voluntary testing. 30 Understandably, potential candidates fear discrimination. 3
Individuals may also be deterred from
participating in research studies which may help them and the
AIDS population in general.3 2
All of these arguments suggest that the adverse effects of
allowing insurance companies to conduct HIV testing before
underwriting health coverage render it bad public policy.
However, to some extent, these costs could be overcome by
such measures as implementing counseling and stricter confidentiality provisions. Accordingly, these objections are comparatively weak in relation to the one which generates the
central theme of this student article - insurance screening is
bad public policy because it precludes some people's access to
health care.
B.

Health Care andJustice in Society

1. Establishing the Right to Health Care
The goal of this student article is to show that AIDS
patients have a right to adequate health care and that health
insurance companies should not be permitted to impose barriers by requiring people to submit to having their blood
screened for HIV. The right to health care cannot be proven in
any absolute way - that is, it is not a natural right, nor is it a
Constitutional right. Rather, I submit that in the context of the
American society and its health care system, for the United
States to allow those who, ironically, are most in need of health
care services to be deprived of them is inhuman.
One may ask from where a right to health care arises. The
answer is a complex one. We must look to our society, to the
28.
29.
30.
31.

Id. at 1800-01.
Id at 1801 & n.16.
Id. at 1802.
Id. (citing INSTITUTE OF MEDICINE,
CONFRONTING AIDS 169 (1986)).
32. Id.

NATIONAL ACADEMY OF SCIENCES,
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functions of health care, to the priority which our society has
placed upon health care institutions, and to the strength of the
needs of AIDS patients and other catastrophically ill persons.
If this combination is strong enough, then one may say that a
right has arisen - a right which is powerful enough to entitle
one to a particular share of society's health care resources.
Reduced to its simplest terms, a person's right to access to
health care and the duty of society to provide it rest on two
concepts. The first has to do with being human - what it
means and what it requires. The second relates to community
and society, specifically, how individuals and social entities
interact with and respond to each other.
Basic human needs must be satisfied for human functioning to occur. One may establish a hierarchy and determine that
those needs are basic which must be satisfied so that wellbeing, that is proper human functioning, is not endangered."3
Readily apparent among these needs would be food, shelter,
and medical care in times of illness. These needs apply to the
disadvantaged as well as to the advantaged. They are intrinsically human. We must meet them if we are to act to our human
potential, to fulfill any of our purposes. 34 Each of us recognizes how this applies to ourselves, and, conversely we should
35
recognize and respect it in others.
It is reasonable to suggest that some criterion must be
established in order to distinguish between true needs and
mere wants.3 6 Again, we look at human functioning. We
require a certain degree of health in order to pursue our lives
to take advantage of the opportunities which are open to us,
to find happiness and to find satisfaction. We define health as
the absence of disease. When we are sick, our ability to pursue
opportunities which would otherwise be available to us is
impaired. If the sickness is serious enough, we need health care
whether or not we actually want it.
Health care institutions, those whose function it is to help
us regain health and overcome disease, play an important role
in our society. We hold the medical profession in high esteem.
33.

See generally Daniels, Health-CareNeeds and DistributiveJustice, 10 PHIL.

& PUB. AFF. 146, 149-54. Daniels draws upon the work of the American
philosopher, John Rawls. Id. at 160-68.
34. See generally A. GEWIRTH, HUMAN RIGHTS 199-200 (1982) and
Daniels, supra note 33, at 152-54.
35. Gewirth refers to this as the Principle of Generic Consistency
(PGC). "Act in accord with the generic rights of your recipients as well as
yourself." A. GEWIRTH, supra note 34, at 3.
36. See Daniels, supra note 33, at 153-54.
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As a society, we have invested large amounts of time and
money in medical facilities and medical technology. This
strong commitment reflects the importance which American
society has placed on health care. Different types of health care
services include the preventive (to maintain health), the curative (to alleviate illness), and the rehabilitative (to help cope
with the effects of illness or injury)., 7 Another is the palliative,
such as the care for the terminally ill which hospices provide.
2.

Catholic Social Teaching

Catholic social teaching, which emphasizes social justice,
human dignity, and human rights recognizes a right to health
care. We regard health care needs as objectively important
because health is so vital in enabling us to accomplish our lifetime goals, to pursue available opportunities, to restore, maintain or compensate for deficiencies in human functioning.
Catholic social teaching emphasizes human qualities and
human life. In his 1963 encyclical, Pacem in Terris, Pope John
XXIII ranked the right to health care highly, placing it before
the right to freedom of speech and association."8 In addressing
personal and bodily rights, the Pope noted that all have "the
right to life, to bodily integrity, and to the means which are
necessary and suitable for the proper development of life; these
are primarily food, clothing, shelter, medical care. . . . , Further, in their 1981 Pastoral Letter, "Health and Health Care,"
the American Catholic Bishops applied the touchstone of Catholic social teaching - the sanctity of human life and human
dignity - in affirming a right to health care.4" Similar to the
rationale discussed in the preceding section, Catholic social
37.

Id. at 158.
Part I, reprintedin ENCYCLICAL LETTER OF His HOLINESS JOHN XXIII
BY DIVINE PROVIDENCE POPE 7 (Vatican Polygot Press ed. 1963).
39. Id.
40. Every person has a basic right to adequate health care. This
right flows from the sanctity of human life and the dignity that
belongs to all human persons, who are made in the image of God. It
implies that access to that health care which is necessary and suitable
for the proper development and maintenance of life must be
provided for all people regardless of economic, social or legal status.
Special attention should be given to meeting the needs of the poor.
With increasingly limited resources in the economy, it is the basic
rights of the poor that are frequently threatened first. The Church
should work with the government to avoid this danger.
U.S. Bishops' PastoralLetter on Health and Health Care, reprinted in 11 ORIGINS
396, 402 (1981). See also CATHOLIC HEALTH AsSOCIATION OF THE UNITED
STATES, JUSTICE AND HEALTH CARE 34 (M.J. Kelly ed. 1985).

38.
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teaching recognizes a right to health care as a means of preserving human functioning.
Currently, no known cure exists for AIDS. Accordingly, a
full restoration of normal human functioning is not possible.
Rather, treatment for AIDS patients can prolong to the greatest extent possible a level close to normalcy and can serve to
minimize the deviation from normalcy.4" Additionally, recent
findings on drug therapy are optimistic about the efficacy of
drugs in delaying the onset of AIDS in HIV-infected but
asymptomatic people, thereby extending the time that they may
pursue their normal everyday lives.4 2
3.

The Obligation Which Arises from the Right

The above discussion has sought to establish that health
care is special in our society and why this is so. It has tried
shown that, in the context of our society, because of the close
nexus between receiving health care and fulfilling one's human
purposes, health care is an objectively important need, so fundamental and so basic that it rises to the level of a right.
The next step is to determine who has the obligation to
fulfill the right. Again, this must be considered in terms of the
context of medical care in our society. Who controls the allocation of health care resources in our society? As stated earlier, a
multitude of public and private entities are involved. The institutions which govern our health care resources are numerous
and diverse. Some are public and others are private. Some are
church-affiliated and others are secular. Some are administrative and others provide direct care. Many universities have
medical schools, and major cities usually have many hospitals,
often including some which are specialized.4" In light of the
41. Note that Daniels casts some doubt on the application of needsbased reasoning to terminal care, since full restoration to normal functioning
cannot be achieved. Daniels, supra note 33, at 169, 171. However, it seems
relevant if we - think of health care for AIDS patients as a means of
approximating normalcy to the greatest extent possible or maintaining or
prolonging it.
42. See infra notes 68-86 and accompanying text.
43. For example, Boston medical facilities include Children's Hospital
Medical Center; Dana Farber Cancer Institute; Shriners Burns Institute
(provides free medical care for children who are burn victims); Massachusetts
Eye, Ear, Nose and Throat Infirmary; Joslin Diabetes Institute; Brigham and
Women's Hospital; St. Margaret's Hospital for Women; MacLean Hospital
(psychiatric care); Spaulding Rehabilitation Center; Beth Israel Hospital;
Massachusetts General Hospital; New England Deaconess Hospital; New
England Baptist Hospital; New England Medical Center; and Boston
University Medical Center.
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importance which society has placed on health care, the
responsibilities of the various players in the health care sector
are heavy. Accordingly, even the private players cannot act in a
purely capitalistic and free-market fashion. Rather, to some
extent, they must respond to human needs and human rights.
Sickness, well-being, health, and health care are all very personal individual matters. Because of the personal nature of
health-related issues, decision-makers must maintain a sensitivity to and a respect for the individual and society's relationship
to individuals. None of the entities involved has unlimited
resources and none should assume the entire burden of caring
for all the sick or for all AIDS patients, for that matter. Yet,
when one entity which has voluntarily placed itself in a pivotal
role in the health care system - such as the private insurance
system - consciously decides to exclude a group, to effectively
deprive that group of resources and services which it needs to
maintain some level of physical well-being, I suggest that a
social injustice results.4 4
It is helpful to consider the rights and relative positions of
AIDS victims and insurers, specifically insurers' rights to profits
and their available resources as opposed to AIDS victims'
rights to health care and their resources. One who asserts his
own rights, should, as a practical matter, acknowledge these
rights in others. This is so because of the equality with which
individuals or entities hold the rights. One should not deprive
another of a right when it would not be burdensome for that
person or entity to fulfill the right; because of their relative
positions, the more advantaged has a duty to the less
advantaged.4 5 Both public and private health care institutions,
because of their particular positions in the health care field and
their control over resources, must cooperate with each other.
When an insurance company decides to exclude groups of
those most in need of health care from coverage, an injustice
results. In our society, having health insurance serves as a
proxy for receiving health care. Insurers violate justice when
44. This is particularly true in light of the fact that private insurers have
opposed a national health insurance program. If the private health insurance
industry is so determined to maintain its position of control in the health care
sector, it seems only fair that it assume some of the burden. See, e.g., Schatz,
supra note 13, at 1805 (citing Hanson, The Private Insurance Industry and State
Insurance Regulatory Activities as Alternatives to Federally Enacted Comprehensive
National Health Insurance Legislation, 6 U. TOL. L. REV. 677, 737 (1975) and
Fuchs, From Bismarck to Woodcock: The "Irrational" Pursuit of National Health
Insurance, 19J.L. & EcON. 347 (1976)); Gifford, An Insidious Test for AIDS, N.Y.
Times, Dec. 14, 1989, at A31, col. 3.
45. See generally A. GEWIRTH, supra note 34, at 199-202.
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they implement testing procedures and effectively deprive people in need when, at least according to current data,4 6 it would
not be excessively burdensome to accommodate them.
The main objective of this student article is to suggest that
private insurance companies should not be exempted from the
responsibility to care for AIDS patients. Quite simply, the private sector should honor its social obligation to the community.4 7 However, insurers should not be forced into insolvency
by providing coverage to AIDS patients. Such a result would
render all insureds unprotected and the system would clearly
fail. Yet, neither should their freedom to contract be absolute,
in view of the equities at stake. True legitimate concern for
financial viability must be distinguished from exaggerated
"pseudo-fear" feigned to shield insurance companies from all
obligation. A fair policy would incorporate the resources and
concerns of insurers and other public and private providers of
health care. First, a fair determination of the capacity of insurance companies to withstand insurance losses requires a consideration of cost estimates. Factors affecting cost include inpatient length of stay, availability of alternatives to inpatient
care, patient population and new treatments and therapies.
Despite the significant cost of AIDS, state commissions believe
that the disease is not yet affecting the solvency of insurance
companies. 48 Although most people are insured through
group health insurance plans, insurance companies are preoccupied with the people who apply for individual health insurance - a much smaller number. Insurers maintain that the
pool of people is too small to spread the costs of AIDS patients.
However, at least for now, that is not true. The rising burden
of AIDS still remains small in relation to the general increase in
medical costs.49 Nonetheless, the costs of AIDS care are sub46. Currently, at least, the actual cost for caring for a person with AIDS
is substantially less than insurance companies had previously estimated.

Gifford, supra note 44.
47. See Pastor, AIDS Patient Care: A Social Responsibility, HEALTH
PROGRESS, Mar. 1988, at 28, 30 (citing A.A. BERLE, JR., THE TWENTIETH
CENTURY REVOLUrION 167-69 (1954)):

[Corporation managements] must consider the kind of a community
in which they have faith, and which they will serve, and which they
intend to help to construct and maintain. In a word, they must
consider at least in its more elementary phases the ancient problem
of the "good life" and how their operations in the community can be
adapted to affording or fostering it.
48. Editorial, Insurers' Excessive Fear ofAIDS, N.Y. Times, Aug. 8, 1989,
at A18, col. 1.
49. Id. Kevin Foley, deputy superintendent of the New York State
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stantial. Wherever possible, these costs should be minimized,
and policies which are as creative, innovative, and efficient as
possible should be implemented. I do not suggest that insurers
abandon their profit-making goals, but rather that they look at
their resources and at their important role in American health
care. They should compromise with other public and private
players in the health care sector in assuming some fraction of
the cost of caring for AIDS patients. For example, when insurers cover relatively inexpensive modes of health care, they
encourage these and help to effect overall cost savings.
In Catholic social teaching, the cooperation at issue is
referred to as socialization.5" Over twenty-five years ago, in
Mater et Magistra, Pope John XXIII recognized that complex
social structures implied the need for complex social relationships."' Currently, socialization must take place among insurance, governmental, health, and corporate entities.5 2 Catholic
social teaching addresses these entities relative to achieving
justice in health care. 53
The Church's social teaching finds its roots in human dignity. In Gaudium et Spes, the Pastoral Constitution "On the
Church in the Modem World" addressed human fear and anxiety, and the Christian duty to alleviate these conditions.5 4 The
document notes that humans achieve dignity through community. "Human dignity is expressed in human community by
human rights, which are attained and assured through structures of social justice."' 55 Proponents of social justice evaluate
Insurance Commission states that "[t]here is no question the system is being
strained. But it's a little hysterical to say that AIDS is driving the problem."
In 1988, Empire Blue Cross and Blue Shield of New York paid out $100
million. While a large and growing amount, it still represents only 2.2% of
all claims. Id.
50. CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES, supra note
40, at 33. In Mater et Magistra, this concept is addressed in paragraphs 59-67:
"the multiplication of social relationships, that is, a daily more complex
interdependence of citizens, introducing into their lives and activities many
and varied forms of association."
51. Id. at 34 (citing Mater et Magistra, paras. 59-67).
52. Id.
53. Id.
54.

Id. at 35 (citing

GAUDIUM ET SPES: PASTORAL CONSTITUTION ON THE

CHURCH IN THE MODERN WORLD, Document of Vatican Council II (Vatican
City, 1965), para. 1, in THE GOSPEL OF PEACE AND JUSTICE (J. Gremillion ed.

1976)).
55.

Id. at 36 (citing GAUDIUM

ET SPES, para.

24 et seq.).
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social structures and systems by their provisions for human
dignity and human rights.5 6
In a recent encyclical on social concerns, Sollicitudo Rei
Socialis,5 7 Pope John Paul II addressed the need to respect the
development of the human person, calling for "a lively awareness of the need to respect the right of every individual to the
full use of the benefits offered by science and technology."" 8
The Pope called for a preference for the poor "which cannot
but embrace the immense multitudes of the hungry, the needy,
the homeless, those without medical care and, above all, those
without hope of a better future."5 9 To ignore them would
mean becoming like the "rich man who pretended not to know
the beggar Lazarus lying at his gate." 6 ° Catholic social teaching, therefore, recognizes the obligations of the advantaged
toward the less advantaged.
In recognizing the challenge which AIDS presents, the
California Catholic Conference addressed two objectives
towards serving the public good. 6 ' They are first, preserving
and protecting human dignity while ensuring the rights of all,
and second, caring for those in need of help. Fairness and caring were emphasized.6 2 The Conference stated that a goal for
AIDS legislation should be to provide adequate medical care6 3
and called for a public policy which would "demonstrate
regard for the dignity of persons with AIDS or ARC."'
Furthermore, "[1]egislation must support and promote... community-based services, disability and health-care coverage, and
[a right] to . . .insurance."'65 In addition to their broad mandate that responsible society ensure that AIDS victims receive
adequate care, the bishops specifically recommended that policy encourage hospitals specifically to implement services for
AIDS patients, and to support hospice and home care programs. Recognizing that an integration of health care services
involving AIDS units and outpatient and community based programs would alleviate the burden on health care providers, par56.

Id. at 37. See also POPE JOHN

CENTER, SCARCE MEDICAL RESOURCES

AND JUSTICE (1987).

57.
58.
59.
60.
61.

John Paul II (Dec. 30, 1987), reprintedin 17 ORIGINS 641 (1988).
Para. 33, reprinted in id. at 652.
Para. 42, reprinted in id. at 656.
Id. (citing Luke 6:19-31).
California Catholic Conference, Public Policy Regarding AIDS/ARC,

reprinted in 17 ORIGINS 561 (1988).

62.
63.
64.
65.

Id.
Id.
Id. at 563.
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ticularly in those areas in which the virus is most concentrated,
the bishops called for a "new and coordinated response among
the different levels of government, the private sector, and voluntary organizations. 66
The relationship between capitalistic organizations and the
communities in which they reside is an intimate one. Organizations often derive their profits in their communities, and their
decisions can exert a significant impact. The potential social
impact is particularly visible in the case of health insurers and
HIV testing. Insurers are not exempt from the requirements of
making society just. Where the health insurance industry fails
to incorporate the principles of justice into its goals independently, public policy should respond with coercive means. Ideally, policymakers will recognize that health care is a complex,
interdependent system, in which many players fulfill particular
roles.
III.

PROVIDING AND PAYING FOR

AIDS

CARE

Although this student article primarily focuses upon the
duties of insurance companies toward AIDS patients, insurance
companies are not exclusively responsible for financing health
care. Rather, they share the responsibility With others who
administer and fund care to AIDS patients. Because of the
interrelationships among the various members of the patchwork health care system, what affects one necessarily impacts
upon the others. Various elements of society including the
local communities, hospitals, drug companies, and public
insurers67 must act in concert with private insurers to ensure
health care for AIDS patients. Each has a unique role and a
carefully constructed combination of efforts will facilitate the
optimal policy.
Private and public insurers, hospitals, and communities are
limited in the amount of resources which they can direct to
AIDS care. Accordingly, these scarce resources must be allo66. Id. at 564.
67. Note that detailed examination of the complexities of such
programs as Medicaid and Medicare is beyond the scope of this paper which
focuses upon private insurers. However, in general, such programs can be
instrumental in furthering the right to health care by reducing their barriers
and to the extent that they are able, increasing their funding levels. For more
on the role of Medicaid and Medicare, see Buchanan, State Medicaid Coverage of
AZT and AIDS-Related Policies, 78 AM. J. PUB. HEALTH 432 (1988); National
Health Law Program, Health Benefits: How the System Is Responding to AIDS, 22
CLEARINGHOUSE REV. 724 (1988); Rowe & Ryan, Comparing State-Only
Expendituresfor AIDS, 78 AM. J. PUB. HEALTH 424 (1988).
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cated to ensure the fairest distribution and to provide the most
appropriate level of care for the individual with respect to his
condition and prognosis. For some, this may be hospital care,
for others, drug therapy, and for still others, home or hospice
care. A public policy should be sensitive to the various needs
of AIDS patients and should enable them to obtain the care
they require. For example, when insurance covers only hospital care, which is very expensive, it encourages people to seek
this kind of care when a less costly mode may be more beneficial and more economically efficient. The following section of
this student article considers the current modes of treatment
for AIDS and how the costs for these treatments have been
allocated. Moreover, it suggests ways to increase the fairness
with which these costs are distributed within society.
A.

Drug Therapy

Treatment with drugs which delay and ameliorate the
effects of AIDS can vastly improve the lives of those with AIDS
and HIV infection. Research during the summer of 1989 led to
a change in perception of the AIDS virus as an "invariably fatal
disease that killed sufferers quickly once they developed symptoms," to one whose effects can be postponed for years if those
who are infected receive drugs before they begin to experience
symptoms. 68 As of yet, one of these drugs, azidothymidine
(AZT), which is made by the Burroughs Wellcome Company,
has been approved to treat AIDS directly and has been on the
market since March 1987.69 AZT works by slowing the multiplication of the AIDS virus in cells. By reducing the number of
opportunistic infections and increasing the number of healthy
cells, AZT can improve the lives of AIDS patients. One of the
most expensive drugs ever sold, until recently, AZT cost
patients with AIDS up to $8,000 a year. In addition, researchers found that another drug, pentamidine, held off the deadly
type of pneumonia which often accompanies AIDS, increasing
the time many patients would require AZT by prolonging their
lives. 70 Because of these findings, the National Institute of
Allergy and Infectious Disease estimated that up to 400,000
infected people who do not exhibit symptoms might be eligible
68.

Hilts, AIDS Drug's Maker Cuts Price by 207a, N.Y. Times, Sept. 19,

1989, at Al, col. 1, CI0, col. 3.
69. Id. at Al, col. 1.
70. Id. at C10.
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for AZT use, in addition to the 100,000 to 200,000 with mild
symptoms, and the 45,000 presently sick with AIDS. 7
The findings presented major implications for the cost of
treatment; people will require AZT earlier and longer. Accordingly, analysts predicted worldwide sales of AZT to rise to
$880,000 by 1992, while another predicted sales to rise from
$230 million to $1 billion in 1989.72 Activists responded to
this expected increase in demand for the often prohibitively
costly drug by protesting to Burroughs Wellcome. Critics
accused the company of "price gouging" and of preventing
those without health insurance from obtaining the drug.73 In
response to the protest, increased demand, and lower production costs, Burroughs Wellcome decided to lower the cost by
20%, reducing cost to advanced patients to $6,500 and to
asymptomatic patients to $2,700. 74
In addition, in an even more meaningful response,
Lyphomed, maker of pentamidine, announced that it would
give the drug away to the uninsured, although it would not
reduce the price for others. 75 Although AIDS patients and
advocates had often severely criticized the company for
overcharging for the drug, the company maintained that it was
giving the drug away not because of this pressure, but rather
because it is "a socially responsible company and is committed
to being part of the solution, making this drug available to the
patients who need it."'76 This event marked the first time a
company gave away approved drugs to needy patients in the
United States.7 7 In the United States, Lyphomed's wholesale
price is $99.54 per vial, while doctors and pharmacists often
charge $150 to $200 per vial. Before the announcement, advocates had begun trying to obtain the drug from England, where
it is much less expensive - $30 per vial. At least 200,000
American AIDS patients require one vial of the drug monthly
71. Freudenheim, AZT Maker Expected to Reap Big Gain, N.Y. Times, Aug.
19, 1989, at 8, col. 1.
72. Moreover, a pharmaceutical analyst with Salomon Brothers in New
York indicated his belief that the company has already recovered its initial
investment of $80 million to $180 million in the drug, and estimates that the
company enjoys annual profits ranging from $25 million to $100 million,
depending on the method of calculation. Hilts, supra note 68, at C 10, col. 5.
73. Id. at AI, col. 1.
74. Id. at Al, CIO.
75. Kolata, Criticized on AIDS Drug, Maker Giving Some Away, N.Y. Times,
Oct. 12, 1989, at 1, col. 1.
76. Id. at 11, col. 5.
77. Id.
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to prevent pneumocystis carinii pneumonia, the leading killer
of people with AIDS.
These two examples demonstrate that, whether motivated
by negative publicity, threatened business, sincere social
responsibility, or a combination of these factors, private entities can respond and have responded to their obligation to contribute to the costs of caring for AIDS patients. To Burroughs
Wellcome and Lyphomed, one way or another, it has been
made clear that an epidemic of a fatal disease does not provide
an appropriate opportunity for unlimited profiteering. Private
health insurers should learn from the examples of these pharmaceutical companies.
Although AZT usually extends the lives of those who take
it, it is most beneficial in the first 12 to 15 months of the disease's course. Beyond that, the death rate increases and the
virus may resist the drug.7 8 In addition, some patients cannot
tolerate AZT because of its high toxicity. Accordingly, clinicians and AIDS activists have been pressuring the Food and
Drug Administration to approve those experimental drugs
which serve as alternatives to AZT.7 9 Many insurers restrict the
availability of effective but not yet approved drugs to AIDS
patients, by excluding "experimental" drugs from coverage.8 °
Drugs are labeled "experimental" if they are prescribed for
conditions other than those which the Food and Drug Administration officially lists. 8 ' For example, some insurers refuse to
pay for AZT when it is used in a preventive capacity by those
who are infected and show immunological depletion, but who
have not developed AIDS.8 2 Similarly, many insurers will not
pay for the spray version of the drug pentamidine which is used
to prevent pneumonia, although they will pay for it when used
intravenously in a hospital to treat pneumonia.8 " Those who
treat and prescribe drugs to AIDS patients realize that a policy
78. Findlay, The Emerging Strategy to Contain AIDS, U.S. NEWS & WORLD
June 19, 1989, at 46.
79. Id. Bristol-Myers Co. has been working on an anti-viral drug called
DDI which works similarly to AZT. Activists are determined to make this and
drugs like it widely available to those in need of treatment. See Painter, A Plan
to Dispense AIDS Drugs, USA Today, Aug. 18, 1989, at ID, col. 2.
80. Boodman, Insurers Balk at Experimental Drugs, Washington Post, Mar.
28, 1989, at Z7.
81. Id.
82. Note that the Eighth Circuit Court of Appeals recently affirmed a
Missouri District Court ruling that required the state's Medicaid program to
pay for AZT treatment as part of the regimen of patients without full-blown
AIDS. Weaver v. Reagen, 886 F.2d 194 (8th Cir. 1989).
83. Boodman, supra note 80.
REP.,
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which allows insurance companies to commandeer who is
treated with what drug and when is a policy devoid of logic.84
Because patients are denied "experimental" treatments, they
must often wait until they are sick enough to be admitted to the
hospital to receive treatment - treatment which is usually
more expensive than the preventive "experimental" drugs that
could have kept them out. This irony directly contradicts the
spirit of the right to health care which emphasizes maintaining
a level of human functioning as close to normal as possible.8 "
Drug therapy is emerging as a major weapon in the fight to
spare AIDS victims from some of the disease's cruelest effects.
Although drugs such as AZT cannot cure the disease, they can
provide important benefits to those patients lucky enough to
obtain them. Public policy should facilitate increased distribution of these drugs by decreasing the restrictive powers which
insurance companies now enjoy. Cost benefits also arise when
insurers subsidize drug therapy. For example, since patients
who receive AZT are less vulnerable to opportunistic infections, they may require less hospital care. Some estimate that
AZT use may reduce AIDS-related costs by $11,000 per patient
per year.8 6 In short, to the extent that public and private insurers subsidize the costs of drugs such as AZT, these expenditures may be offset by savings elsewhere. Moreover, and most
84. Peter Hawley, medical director of Washington's Whitman-Walker
Clinic, the area's primary AIDS service organization has stated: "It's really
short-sighted. It's a lot cheaper to pay $1,200 for a year's worth of
aerosolized pentamidine than $12,000, which is the average cost of
hospitalization for pneumocystis." In addition, Dr. Larry Bruni, who
specializes in AIDS treatment in Washington commented that "insurance
companies - not physicians - are deciding who has access to lifesaving
therapy. And the problem is that some of them don't want to spend the
money; they'd rather let the patient die." Id.
85. On a positive note, some cities, such as Chicago, Illinois have
received grants from the National Institute of Allergy and Infectious Disease
which will provide access to AIDS patients to experimental drug therapy and
will allow them to be treated by their own physicians. Garza, Grant to Aid
AIDS Treatment, Chicago Tribune, Oct. 7, 1989, § 1, at 5, col. 4.
One experimental drug which has shown promise is CD4, a genetically
engineered anti-AIDS drug which could prove to be "the ultimate weapon"
against AIDS. Kotulak, Drug Designed to Decoy Virus New Salvo in War Against
AIDS, Chicago Tribune, June 11, 1989, § 1, at 4, col. 1 (quoting Dr. Robert
C. Gallo, National Cancer Institute). See also Science Edges Closer to Designing
Drugs to Defeat AIDS Virus, Wall St. J., Mar. 3, 1989, at 1, col. 1.
For a discussion on the use of "nonvalidated therapies" see Freedman
and the McGill/Boston Research Group, Nonvalidated Therapies and HIV
Disease, HASTINGS CENTER REP., May/June 1989, at 14.
86. Penslar, Who Pays for AZT?, HASTINGS CENTER REP., Sept./Oct.
1989, at 30-31.
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importantly, such a public policy furthers the right to health
care and becomes more "human" by enabling those suffering
from AIDS and those who are HIV-infected to maintain a level
of normalcy in their everyday lives.
B.

The Role of Hospitals and Hospices

In addition to drug therapy, AIDS patients often require
the services of medical care providers in hospitals, both inpatient and outpatient units, and hospices. The goals of these
providers should always be to help AIDS patients live as normally as possible for as long as possible. Of course, when the
capacity for normal human functioning decreases as the patient
becomes more vulnerable to the disease's cruel effects, the
caretakers must try to maximize their patient's comfort. Like
drug therapy, medical care services for AIDS patients are
expensive, and policymakers should strive to allocate the costs
in an equitable way.
Hospitals must often absorb part of the costs of caring for
AIDS patients. One reason for this is that hospital rates frequently exceed Medicaid reimbursement. Moreover, patients
covered by neither private nor Medicaid coverage may be
unable to pay their hospital bills. Initially, private hospitals
bear the unreimbursed costs of caring for AIDS patients by
profits and operating surplus.8 7 Yet, these costs are shifted to
patients and their insurance companies whose rates are
increased," for, to stay in business, these hospitals cannot
operate indefinitely at a deficit.8 9 It is becoming more difficult
for hospitals freely to "shift" costs, because of an increased
emphasis on cost containment and competition.90 Ultimately,
taxpayers will bear the excess costs of AIDS patients receiving
87.

239

Bloom & Carliner, The Economic Impact of AIDS in the United States,

604, 608 (1988).
88. Id.
89. Hospitals have not been able to meet the costs of caring for AIDS
patients. Private facilities in the Northeast lost more than $200,000 each in
1987, and private institutions in the South lost $3100 apiece. Additionally,
private institutions in the West may have sustained losses. Public hospitals,
which treated the largest proportions of low-income AIDS patients incurred
even greater losses in the Northeast and South. In 1987, the average public
hospital lost more than $600,000. Teaching hospitals were especially
affected. Moreover, in the South, with its extremely restrictive Medicaid
programs, AIDS treatment represents a "financial disaster" for public
hospitals. They also lost more than $600,000 each in 1987. Andrulis,
Weslowski & Gage, The 1987 US HospitalAIDS Survey, 262J. A.M.A. 784, 79394 (1989).
90. Bloom & Carliner, supra note 87, at 608.
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care from public hospitals.9 1 If insurance companies were
forced to share in the costs, the burdens on hospitals and public insurers would be reduced.
Hospitals and insurers, public and private, should
encourage non-conventional modes of treatment. It is ultimately in their best interest to do so, since it will reduce the
financial burdens they incur. Hospitals should assist community groups in implementing creative, cost-efficient methods of
caring for AIDS patients. For example, New York City is planning to convert a former school into a 230-bed nursing home
exclusively for AIDS patients.9 2 The home is scheduled to
open in 1991 and, hopefully, will alleviate the city's overcrowded hospital system by offering a long-term setting for
nonacute patients. Most patients will be covered by Medicaid
or Medicare.93
Insurers can encourage alternatives to hospital care by
covering their costs - again, costs which are less than conventional hospital costs.9 4 For example, "support group infrastructures" which assume some of the burden of caring for
AIDS patients perform such services as providing information
on drug access, offering basic hygiene and nourishment, and
facilitating equipment rental.9 5 In addition, it is possible for
91. Note that a disproportionate burden has fallen on public hospitals
in New York City and San Francisco, since nearly 1/2 of all AIDS cases have
occurred in New York and California. Accordingly, taxpayers in these
locations are disproportionately burdened. Id. This lends added support to
proposals for increasing the availability of less costly hospice and home care
services.
In March 1989, a New York City mayoral panel warned that because of
the increasing number of AIDS patients, hospitals and other health
institutions would lose their ability to care for those needing their services,
since most hospitals reported being filled to nearly 1007o. Lambert, AIDS
Seen as StrainingNew York City Hospitals, N.Y. Times, Mar. 3, 1989, at 9, col. 3.
A study by the National Association of Public Hospitals stated that
hospitals spend an average of $681 a day to care for AIDS patients, but got
back only $545 in payments. Lambert, Concentration of AIDS Cases Posing
Serious Problemsfor Some Hospitals, N.Y. Times, Aug. 11, 1989, at A12, col. 1.
92. Lubasch, Former School to be Converted to AIDS Home, N.Y. Times, Apr.
18, 1989, at B3, col. 1.
93. Id.
94. But, a study showed that while the average cost of an outpatient
clinic visit was $237, average reimbursements were only $63. Lambert,
Concentration of AIDS Cases Posing Serious Problemfor Some Hospitals, supra note
91.
95. Giovanis, Clinical Costs of AIDS Are Multidimensional, HEALTHCARE
FIN. MGMT., Nov. 1988, at 58.
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AIDS patients to receive intravenous medications at home.9 6
Insurance coverage of less expensive, alternative modes of care
would encourage these types of treatment.
Inpatient hospital care is certainly a necessary component
to the realm of treatment offered to AIDS patients, particularly
in the disease's most cruel stages when drastic measures are
necessary. Competent hospital care can provide essential acute
care and enable the patient to return to a level of normalcy.
However, for less seriously afflicted patients, drug therapy and
outpatient treatment provide two benefits. First, they are less
expensive than inpatient care, thereby reducing the overall
financial burden of AIDS. Second, these modes of treatment
enable the patient to maintain a sense of control over his life.
Similarly, when a patient is close to death, hospice care, which
is less expensive than inpatient hospital care may provide a
more comfortable, home-like environment for the patient. The
Seaton Hill Manor in Baltimore, Maryland, is an example of a
nursing home which has established a special unit to care the
needs of AIDS patients. 9 7 Unfortunately a shortage of such
facilities exists.98 Public policy which required private insurers
to cover alternative modes of care would accomplish the dual
goals of lowering overall costs and providing more "human"
treatment for AIDS patients.
IV.

CONCLUSION

Whether to allow health insurers to conduct HIV testing
embodies many other issues - issues which are socially crucial
and presents far-reaching implications. Among the values at
stake are human dignity, human rights, and justice. Ensuring
access to health care fosters each of these values. Working
toward a just society involves various segments of society acting in concert to provide for people's basic needs. For the person with AIDS, health care is a basic need.9 9
96.

Robinson, Hospitals Poised to Offer In-home IV Therapy, HosPIrrALSJuly

20, 1989, at 16.
97. Adams, FinancialProblems Inherent in the Admission of AIDS Patientsinto
Long Term Care Facilities, 10J.L. MED. 89, 99-100 (1989).
98. Eubanks, AIDS Patients Need More Long-term Care Options, HOSPITALS,
Nov. 5, 1989, at 64.
99. This symposium is about AIDS. Accordingly, this student article
addresses the plight which people with AIDS face in obtaining health care
and the obstacle which HIV testing by insurance companies presents.
However, the right to health care of people suffering from other debilitating
and life-threatening diseases such as cancer is equally strong. It does seem,
though, that AIDS has served as the catalyst in demonstrating just how
inadequate and unjust a patchwork health care system can be.
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It is apparent that whatever policy is adopted for insuring
and caring for AIDS patients, no one will be sheltered from the
economic impact. The non-infected public will contribute
either by taxes, increased premiums, or increased health care
costs.10 0 Private insurance companies should not be allowed to
immunize themselves from risk merely by claiming that they
are not part of a social system and that AIDS is society's problem. When they engage in HIV testing, insurers ignore their
social obligation. They should, in contrast, assume responsibility commensurate with the prominent role which they have
assumed in the health care system. Private pharmaceutical
companies and private hospitals have had to cope with the negative effects of AIDS on their profits. Why should private
insurers be allowed to shield themselves by insuring only those
with sufficiently pure blood? Legislation should ensure that
insurers honestly and realistically assess how much of the risk
they can assume. By covering nontraditional modes of care,
insurers may encourage such treatment and ultimately achieve
cost savings for themselves and others. Moreover, hospitals
and communities should tailor programs which serve the needs
of their local AIDS populations in the most innovative, costefficient ways possible.
All should have access to health care. The important role
which health care plays in enabling people to maximize their
human potential justifies this right. The AIDS crisis has highlighted the serious weaknesses in our nation's current health
care system and has underscored society's obligation to provide competent care to those who suffer from AIDS and other
catastrophic illnesses.

100. See Jacoby, Who Will Pay the AIDS Bill?, NEWSWEEK, Apr. 11, 1988,
at 71; Dunne, Who Should Bear the Costs of AIDS Care?, USA TODAY, May 1988,
at 30.

